Orilissa (Elagolix)

Orilissa (Elagolix)

Orilissa

Elagolix

Tablets: 150 mg and 200 mg

AbbVie

Medical Use

Orilissa is a gonadotropin-releasing hormone (GnRH) receptor antagonist prescribed for managing moderate to severe pain due to endometriosis.

Recommended Dosage:

  • -For individuals with normal liver function or mild hepatic impairment: 150 mg once daily for up to 24 months, or 200 mg -twice daily for up to 6 months.
  • For those with moderate hepatic impairment: 150 mg once daily for up to 6 months.

Administration Instructions:

  • -Take Orilissa tablets at the same time each day, with or without food.
  • -Use the lowest effective dose, considering the severity of symptoms and treatment goals.
  • -If a dose is missed, take it as soon as remembered on the same day, then continue with the regular dosing schedule.